HSPA5 and neoplasm: CAR T cells targeting cell surface GRP78 (csGRP78) have been shown to efficiently kill GBM tumor cells and GSCs both in vitro and in vivo, ultimately suppressing xenograft tumor growth without causing significant tissue injuries.